Sofosbuvir achieves sustained response in patients with hepatitis C and HIV
From Skin and Allergy News, 21 July 2014: Treatment with the interferon-free oral nucleotide analog sofosbuvir plus ribavirin achieved high rates of sustained virologic response in patients with HIV coinfected with hepatitis C, according to data from an open-label phase III study. Researchers observed an 82% response rate among treatment-naive patients coinfected with hepatitis C … Continue reading Sofosbuvir achieves sustained response in patients with hepatitis C and HIV
Bianca Nogrady 